-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IQY/sFqg4z8DpM3DxoIrwAOIKKPsI2Q0oimNiM2Aq8IOcOVJd0BwAIhXv2x0JAGI ZAyvneK1Hu9A+ueLwg0e1g== 0000914121-04-000168.txt : 20040209 0000914121-04-000168.hdr.sgml : 20040209 20040209180242 ACCESSION NUMBER: 0000914121-04-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040205 FILED AS OF DATE: 20040209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE LEVI HONG KAYE CENTRAL INDEX KEY: 0001268608 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14907 FILM NUMBER: 04579099 BUSINESS ADDRESS: STREET 1: 1405 LANE CRAWFORD HOUSE STREET 2: 70 QUEENS RD. E. CITY: HONG KONG CHINA STATE: F4 ZIP: 00000 MAIL ADDRESS: STREET 1: 1405 LANE CRAWFORD HOUSE CITY: 70 QUEENS RD. E. STATE: F4 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMTECH INTERNATIONAL INC CENTRAL INDEX KEY: 0000882509 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 391523370 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 150 FAIRWAY DRIVE STREET 2: SUITE 150 CITY: VERNON HILLS STATE: IL ZIP: 60061 BUSINESS PHONE: (847) 573-0033 MAIL ADDRESS: STREET 1: 150 FAIRWAY DRIVE STREET 2: SUITE 150 CITY: VERNON HILLS STATE: IL ZIP: 60061 4 1 p678838-4lee2_ex.xml X0201 4 2004-02-05 0 0000882509 IMMTECH INTERNATIONAL INC IMM 0001268608 LEE LEVI HONG KAYE 1405 CRAWFORD HOUSE, 70 QUEEN'S ROAD CENTRAL HONG KONG CHINA CHINA 1 0 0 0 Common Stock, $0.01 par value 2004-02-05 4 P 0 1000 14.35 A 202602 I By Spouse Common Stock, $0.01 par value 2004-02-05 4 P 0 500 14.62 D 202102 I By Spouse Common Stock, $0.01 par value 2004-02-05 4 P 0 500 14.45 D 201602 I By Spouse Common Stock, $0.01 par value 2004-02-05 4 P 0 1000 14.30 A 202602 I By Spouse Includes (i) 19,900 shares of Common Stock; (ii) 113,353 shares of Common Stock (wife); (iii) 11,312 shares of Common Stock (wife) issuable upon conversion of Series A Convertible Preferred Stock; (iv) 9,050 shares of Common Stock issuable upon conversion of Series C Convertible Preferred Stock; (v) 42,987 shares of Common Stock (wife) issuable upon conversion of Series C Convertible Preferred Stock; (vi) the vested portion of 4,167 shares of an option to purchase 20,000 shares of Common Stock at $21.66 per share by November 5, 2013 (options vest in equal monthly installments over 24 months from date of grant); and (vii) the vested portion of 1,833 shares of an option to purchase 18,000 shares of Common Stock at $14.29 per share by February 2, 2014 (options vest in equal monthly installments over 24 months from date of grant). Includes (i) 19,900 shares of Common Stock; (ii) 112,853 shares of Common Stock (wife); (iii) 11,312 shares of Common Stock (wife) issuable upon conversion of Series A Convertible Preferred Stock; (iv) 9,050 shares of Common Stock issuable upon conversion of Series C Convertible Preferred Stock; (v) 42,987 shares of Common Stock (wife) issuable upon conversion of Series C Convertible Preferred Stock; (vi) the vested portion of 4,167 shares of an option to purchase 20,000 shares of Common Stock at $21.66 per share by November 5, 2013 (options vest in equal monthly installments over 24 months from date of grant); and (vii) the vested portion of 1,833 shares of an option to purchase 18,000 shares of Common Stock at $14.29 per share by February 2, 2014 (options vest in equal monthly installments over 24 months from date of grant). Includes (i) 19,900 shares of Common Stock; (ii) 112,353 shares of Common Stock (wife); (iii) 11,312 shares of Common Stock (wife) issuable upon conversion of Series A Convertible Preferred Stock; (iv) 9,050 shares of Common Stock issuable upon conversion of Series C Convertible Preferred Stock; (v) 42,987 shares of Common Stock (wife) issuable upon conversion of Series C Convertible Preferred Stock; (vi) the vested portion of 4,167 shares of an option to purchase 20,000 shares of Common Stock at $21.66 per share by November 5, 2013 (options vest in equal monthly installments over 24 months from date of grant); and (vii) the vested portion of 1,833 shares of an option to purchase 18,000 shares of Common Stock at $14.29 per share by February 2, 2014 (options vest in equal monthly installments over 24 months from date of grant). Includes (i) 19,900 shares of Common Stock; (ii) 113,353 shares of Common Stock (wife); (iii) 11,312 shares of Common Stock (wife) issuable upon conversion of Series A Convertible Preferred Stock; (iv) 9,050 shares of Common Stock issuable upon conversion of Series C Convertible Preferred Stock; (v) 42,987 shares of Common Stock (wife) issuable upon conversion of Series C Convertible Preferred Stock; (vi) the vested portion of 4,167 shares of an option to purchase 20,000 shares of Common Stock at $21.66 per share by November 5, 2013 (options vest in equal monthly installments over 24 months from date of grant); and (vii) the vested portion of 1,833 shares of an option to purchase 18,000 shares of Common Stock at $14.29 per share by February 2, 2014 (options vest in equal monthly installments over 24 months from date of grant). /s/ Levi Hong Kaye Lee 2004-02-09 -----END PRIVACY-ENHANCED MESSAGE-----